Covista Inc.
Covista (NYSE: CVSA) shares rose about 13% after the company reported Q2 2026 revenue of $501.4 million, up 9.7% year over year, and adjusted EPS of $2.09, about 10% above Wall Street estimates. Operating margin increased to 19% from 16.8%. Covista also issued full-year adjusted earnings guidance above consensus; shares closed around $140.91.
Covista (NYSE:CVSA), formerly DeVry Education Group, reported Q2 CY2026 revenue of $501.4 million, up 9.7% year on year and 3.1% above Wall Street estimates, according to the company. It guided full-year revenue to about $2.07 billion. Non-GAAP EPS was $2.09, 10.4% above consensus, and analysts expect full-year EPS to rise from $8.25 to $8.75.
Covista Inc. (CVSA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cvsa-20260806xex99d1.htm EX-99.1 Exhibit 99.1 Investor Contact: Jeremy Cohen Investor.Relations@Covista.com +1 312-906-6600 Media Contact: Maureen Bender CovistaMedia@Covista.com +1 313-319-4732 Covista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; I
Over the past 7 days, alphai's AI scored 3 news stories mentioning CVSA (Covista Inc.). Coverage has skewed bullish: 3 bullish, 0 neutral, and 0 bearish.
Recent CVSA coverage spans insider activity, earnings and corporate actions.
In the last 30 days, CVSA insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($702K). The most active reporter was Beard, Stephen W., Chairman & CEO, with 1 filing. 100% of activity was filed under pre-arranged Rule 10b5-1 plans.
The Q2 beat plus above-consensus full-year adjusted earnings guidance is a near-term re-rating catalyst for CVSA, with operating margin expansion supporting quality of earnings.
Beat on revenue and adjusted EPS, with full-year revenue and EPS guidance roughly in line, but growth deceleration is a key risk.
The 8-K discloses a full earnings print plus forward guidance, which can drive near-term repricing of growth and margin expectations.
Board expansion and new independent director appointments are unlikely to change near-term fundamentals, but can affect governance expectations and committee composition.
This is a routine insider sale disclosure with limited direct signal value, but it can slightly affect near-term sentiment.
alphai scores every news story that mentions CVSA with an AI model for sentiment and relevance, and aggregates insider trades from Covista Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Covista (NYSE: CVSA) shares rose about 13% after the company reported Q2 2026 revenue of $501.4 million, up 9.7% year over year, and adjusted EPS of $2.09, about 10% above Wall Street estimates. Operating margin increased to 19% from 16.8%. Covista also issued full-year adjusted earnings guidance above consensus; shares closed around $140.91.
4 min readCovista (NYSE:CVSA), formerly DeVry Education Group, reported Q2 CY2026 revenue of $501.4 million, up 9.7% year on year and 3.1% above Wall Street estimates, according to the company. It guided full-year revenue to about $2.07 billion. Non-GAAP EPS was $2.09, 10.4% above consensus, and analysts expect full-year EPS to rise from $8.25 to $8.75.
5 min readCovista Inc. (CVSA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cvsa-20260806xex99d1.htm EX-99.1 Exhibit 99.1 Investor Contact: Jeremy Cohen Investor.Relations@Covista.com +1 312-906-6600 Media Contact: Maureen Bender CovistaMedia@Covista.com +1 313-319-4732 Covista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; I
6 min readCovista Inc. (CVSA) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Covista Inc._July 28, 2026 0000730464 false 0000730464 2026-07-28 2026-07-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earl
2 min readBeard, Stephen W. (Chairman & CEO) sold 5,291 shares of Covista Inc. (CVSA) at $132.75 ($0.70M total) on 2026-07-13 under a Rule 10b5-1 trading plan.
1 min readPhelan Robert J. (Chief Financial Officer) sold 5,314 shares of Covista Inc. (CVSA) at an average of $135.40 ($135.39–$135.41, $0.72M total) across 2 trades over 2026-07-07 to 2026-07-08 under a Rule 10b5-1 trading plan.
2 min readBECK DOUGLAS G. (SVP, GC, Corp. Sec & ISS) sold 5,089 shares of Covista Inc. (CVSA) at an average of $135.37 ($135.34–$135.40, $0.69M total) across 2 trades over 2026-07-07 to 2026-07-08 under a Rule 10b5-1 trading plan.
1 min readCovista filing shows Chairman and CEO Stephen W. Beard sold about 5,300 shares near an 8-month high price, according to the report. The company said the sale covered shares above its ownership requirements and was executed under a trading plan set in December 2025. Beard still holds over $55 million in Covista equity.
3 min readBeard, Stephen W. (Chairman & CEO) sold 5,291 shares of Covista Inc. (CVSA) at an average of $130.45 ($130.14–$130.78, $0.69M total) across 2 trades over 2026-06-10 to 2026-06-11 under a Rule 10b5-1 trading plan.
2 min read
